Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
16 August 2016 - 6:40AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
SEC
FILE NUMBER
000
– 192997
NOTIFICATION
OF LATE FILING
CUSIP
NUMBER
67052F102
(Check
One):
☐
Form 10-K ☐ Form 20-F ☐ Form 11-K
☒ Form 10-Q ☐
Form 10-D ☐ Form N-SAR
☐ Form N-CSR
For
Period Ended:
June 30, 2016
☐
|
Transition Report on
Form 10-K
|
☐
|
Transition Report on
Form 20-F
|
☐
|
Transition Report on
Form 11-K
|
☐
|
Transition Report on
Form 10-Q
|
☐
|
Transition Report on
Form N-SAR
|
For
the Transition Period Ended: _________________
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
NuGene
International, Inc.
Full Name of Registrant
Former Name if Applicable
17912
Cowan, Suite A
Address of Principal Executive Office
(Street and Number)
Irvine,
California 92614
City, State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
☒
|
(a)
|
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
(b)
|
The subject annual
report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof,
will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or
transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date; and
|
|
|
(c)
|
The accountant's statement
or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof,
could not be filed within the prescribed time period.
The
Registrant is unable to file its annual report on Form 10-K within the prescribed time period because the Registrant requires
additional time to finalize its financial statements for review by its independent accountant.
PART
IV — OTHER INFORMATION
(1)
|
Name and telephone
number of person to contact in regard to this notification
|
|
Keith
A. Rosenbaum
|
949
|
851-4300
|
|
(Name)
|
(Area Code)
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of
the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed ? If answer is no, identify report(s).
☒
Yes ☐ No
|
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal
year will be reflected by the earnings statements to be included in the subject report or portion thereof ?
☐
Yes ☒ No
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
|
NuGene
International, Inc.
(Name of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date: 15
August 2016
|
By:
|
/s/
M. Saeed Kharazmi
|
|
|
M. Saeed Kharazmi
|
|
Title:
|
CFO
|
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Apr 2024 to May 2024
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From May 2023 to May 2024